Compare Procter & Gamble Health with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs TTK HEALTHCARE - Comparison Results

PROCTER & GAMBLE HEALTH     Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH TTK HEALTHCARE PROCTER & GAMBLE HEALTH/
TTK HEALTHCARE
 
P/E (TTM) x 44.4 20.9 212.8% View Chart
P/BV x 4.7 1.4 339.2% View Chart
Dividend Yield % 10.0 1.1 904.9%  

Financials

 PROCTER & GAMBLE HEALTH   TTK HEALTHCARE
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Dec-18
TTK HEALTHCARE
Mar-19
PROCTER & GAMBLE HEALTH/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs3,5491,215 292.1%   
Low Rs1,301610 213.3%   
Sales per share (Unadj.) Rs511.4444.4 115.1%  
Earnings per share (Unadj.) Rs61.317.2 355.4%  
Cash flow per share (Unadj.) Rs74.027.6 267.9%  
Dividends per share (Unadj.) Rs440.005.00 8,800.0%  
Dividend yield (eoy) %18.10.5 3,311.3%  
Book value per share (Unadj.) Rs927.8177.9 521.4%  
Shares outstanding (eoy) m16.6014.13 117.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.72.1 230.9%   
Avg P/E ratio x39.652.9 74.8%  
P/CF ratio (eoy) x32.833.0 99.2%  
Price / Book Value ratio x2.65.1 51.0%  
Dividend payout %717.929.0 2,476.4%   
Avg Mkt Cap Rs m40,25712,894 312.2%   
No. of employees `0001.12.3 49.0%   
Total wages/salary Rs m1,3131,307 100.4%   
Avg. sales/employee Rs Th7,486.72,715.7 275.7%   
Avg. wages/employee Rs Th1,157.6565.3 204.8%   
Avg. net profit/employee Rs Th897.2105.4 851.2%   
INCOME DATA
Net Sales Rs m8,4906,279 135.2%  
Other income Rs m24478 314.7%   
Total revenues Rs m8,7346,356 137.4%   
Gross profit Rs m1,482496 299.0%  
Depreciation Rs m211147 144.0%   
Interest Rs m034 0.0%   
Profit before tax Rs m1,514393 385.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m660-   
Tax Rs m563149 377.8%   
Profit after tax Rs m1,017244 417.5%  
Gross profit margin %17.57.9 221.1%  
Effective tax rate %37.137.9 97.9%   
Net profit margin %12.03.9 308.8%  
BALANCE SHEET DATA
Current assets Rs m15,3432,717 564.7%   
Current liabilities Rs m1,9601,571 124.8%   
Net working cap to sales %157.618.3 863.3%  
Current ratio x7.81.7 452.5%  
Inventory Days Days4932 151.6%  
Debtors Days Days2847 61.0%  
Net fixed assets Rs m1,209991 122.0%   
Share capital Rs m166141 117.5%   
"Free" reserves Rs m15,2352,373 642.0%   
Net worth Rs m15,4012,514 612.5%   
Long term debt Rs m03 0.0%   
Total assets Rs m17,5954,158 423.1%  
Interest coverage xNM12.6-  
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.51.5 32.0%   
Return on assets %5.86.7 86.6%  
Return on equity %6.69.7 68.2%  
Return on capital %10.316.9 60.6%  
Exports to sales %03.6 0.0%   
Imports to sales %00.5 0.0%   
Exports (fob) Rs mNA225 0.0%   
Imports (cif) Rs mNA31 0.0%   
Fx inflow Rs m1,636225 726.6%   
Fx outflow Rs m4,36871 6,142.7%   
Net fx Rs m-2,732154 -1,772.9%   
CASH FLOW
From Operations Rs m-1,304173 -753.2%  
From Investments Rs m12,69797 13,157.7%  
From Financial Activity Rs m-301-307 97.8%  
Net Cashflow Rs m11,093-38 -29,424.1%  

Share Holding

Indian Promoters % 0.0 65.4 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 3.7 491.9%  
FIIs % 1.0 5.2 19.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 25.8 112.8%  
Shareholders   28,591 12,723 224.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   STERLING BIOTECH  PFIZER  ALKEM LABORATORIES  SHASUN PHARMA  SANOFI INDIA  

Compare PROCTER & GAMBLE HEALTH With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 362 Points Higher on RBI Loan Recast; IT and FMCG Stocks Rally(Closing)

Indian share markets ended on a positive note today after the RBI kept the repo rate unchanged at 4%.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (3QFY20); Net Profit Down 8.3% (Quarterly Result Update)

Jan 30, 2020 | Updated on Jan 30, 2020

For the quarter ended December 2019, TTK HEALTHCARE has posted a net profit of Rs 45 m (down 8.3% YoY). Sales on the other hand came in at Rs 2 bn (up 11.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

PROCTER & GAMBLE HEALTH Announces Quarterly Results (2QFY20); Net Profit Down 13.0% (Quarterly Result Update)

Nov 14, 2019 | Updated on Nov 14, 2019

For the quarter ended September 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 358 m (down 13.0% YoY). Sales on the other hand came in at Rs 2 bn (down 0.4% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY20); Net Profit Up 34.3% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 441 m (up 34.3% YoY). Sales on the other hand came in at Rs 2 bn (up 6.1% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

PROCTER & GAMBLE HEALTH 2017-18 Annual Report Analysis (Annual Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

Here's an analysis of the annual report of PROCTER & GAMBLE HEALTH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PROCTER & GAMBLE HEALTH. Also includes updates on the valuation of PROCTER & GAMBLE HEALTH.

More Views on News

Most Popular

These 5 Smallcaps Deserve a Place in Your Coffee Can Portfolio(Profit Hunter)

Jul 28, 2020

When it comes to quality stocks, doing less is more.

Before You Buy Your First Electric Vehicle Consider Buying this Stock(Profit Hunter)

Jul 29, 2020

As competition intensifies in the electric vehicle space, only few will create huge wealth over the years.

Gold or Silver: Which One Should You Buy Now?(Fast Profits Daily)

Jul 24, 2020

Silver and gold are both vying for your attention. Which is the better trade today?

A Zero Loss Strategy that Also Maximizes Returns in Volatile Stock Markets(Views On News)

Jul 24, 2020

Here's how to never lose money in stock markets.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

PROCTER & GAMBLE HEALTH SHARE PRICE


Aug 6, 2020 (Close)

TRACK PROCTER & GAMBLE HEALTH

  • Track your investment in PROCTER & GAMBLE HEALTH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH 8-QTR ANALYSIS

COMPARE PROCTER & GAMBLE HEALTH WITH

MARKET STATS